Diovane



Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 54.4%
Atrial Fibrillation 5.8%
Drug Use For Unknown Indication 3.9%
Pain 3.9%
Product Used For Unknown Indication 3.9%
Bronchopneumonia 2.9%
Depression 2.9%
Diabetes Mellitus 2.9%
Thrombosis Prophylaxis 2.9%
Cardiac Failure 1.9%
Colon Cancer Metastatic 1.9%
Coronary Angioplasty 1.9%
Hypercholesterolaemia 1.9%
Hypotonia 1.9%
Prophylaxis 1.9%
Acidosis 1.0%
Anaemia 1.0%
Blood Pressure 1.0%
Cerebral Infarction 1.0%
Constipation 1.0%
Interstitial Lung Disease 16.7%
Vomiting 10.0%
Death 6.7%
Nausea 6.7%
Toxic Epidermal Necrolysis 6.7%
Tumour Marker Increased 6.7%
Blood Creatinine Increased 3.3%
Blood Potassium Increased 3.3%
Blood Pressure Inadequately Controlled 3.3%
Blood Sodium Decreased 3.3%
Drug Hypersensitivity 3.3%
Drug Ineffective 3.3%
Face Oedema 3.3%
General Physical Condition 3.3%
Hyperkalaemia 3.3%
Malaise 3.3%
Melaena 3.3%
Oedema Peripheral 3.3%
Overdose 3.3%
Renal Failure 3.3%
Concomitant
Hypertension 35.7%
Product Used For Unknown Indication 8.7%
Hormone Replacement Therapy 6.6%
Drug Use For Unknown Indication 5.8%
Diabetes Mellitus 5.7%
Type 2 Diabetes Mellitus 5.5%
Blood Pressure 4.2%
Rheumatoid Arthritis 3.0%
Smoking Cessation Therapy 2.7%
Atrial Fibrillation 2.5%
Prophylaxis 2.4%
Renal Cell Carcinoma 2.3%
Insomnia 2.2%
Pain 2.1%
Hyperuricaemia 1.9%
Angina Unstable 1.8%
Asthma 1.8%
Blood Cholesterol Increased 1.8%
Disseminated Tuberculosis 1.7%
Depression 1.5%
Weight Decreased 10.4%
Vomiting 9.3%
Lymphadenopathy 7.7%
Breast Cancer Female 6.0%
Visual Impairment 6.0%
White Blood Cell Count Decreased 6.0%
Vision Blurred 5.5%
Nausea 4.9%
Renal Failure Acute 4.9%
Tremor 4.9%
Pain In Extremity 4.4%
Drug Ineffective 3.8%
Headache 3.8%
Pneumonia 3.8%
Myocardial Infarction 3.3%
Paraesthesia 3.3%
Pyrexia 3.3%
Blood Creatinine Increased 2.7%
Breast Cancer 2.7%
Cerebrovascular Accident 2.7%
Interacting
Hypertension 40.0%
Prophylaxis 11.4%
Type 2 Diabetes Mellitus 11.4%
Hyperuricaemia 8.6%
Hyperlipidaemia 5.7%
Osteoporosis Prophylaxis 5.7%
Acidosis 2.9%
Anaemia 2.9%
Cardiac Failure 2.9%
Helicobacter Gastritis 2.9%
Hypercholesterolaemia 2.9%
Hyperparathyroidism Secondary 2.9%
Circulatory Collapse 66.7%
Renal Failure Chronic 33.3%